Accessibility Menu

Vyome

(NASDAQ) HIND

Current Price$2.19
Market Cap$15.16M
Since IPO (2025)-85%
5 Year-100%
1 Year-77%
1 Month-4%

Vyome Financials at a Glance

Market Cap

$15.16M

Revenue (TTM)

$1.34M

Net Income (TTM)

-$13.25M

EPS (TTM)

-$12.41

P/E Ratio

-0.17

Dividend

$0.00

Beta (Volatility)

0.67 (Low)

Price

$2.19

Volume

106

Open

$2.19

Previous Close

$2.19

Daily Range

$2.19 - $2.19

52-Week Range

$1.75 - $18.60

Estimated Earnings Date

Aug 13, 2026

HIND News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vyome

Industry

Pharmaceuticals

Employees

18

CEO

Venkateswarlu Nelabhotla, MBA

Headquarters

Princeton, NJ 08540, US

HIND Financials

Key Financial Metrics (TTM)

Gross Margin

48.16%

Operating Margin

-401.91%

Net Income Margin

-985.46%

Return on Equity

-302.13%

Return on Capital

-111.07%

Return on Assets

-130.11%

Earnings Yield

-5.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.16M

Shares Outstanding

7.02M

Volume

106

Avg. Volume

27.44K

Financials (TTM)

Gross Profit

$647.66K

Operating Income

-$5.40M

EBITDA

-$13.43M

Operating Cash Flow

-$3.07M

Capital Expenditure

-$1.00

Free Cash Flow

-$3.07M

Cash & ST Invst.

$8.80M

Total Debt

$22.55K

Vyome Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$31.59K

-97.2%

Gross Profit

$14.04K

-97.9%

Gross Margin

44.44%

N/A

Market Cap

$15.16M

N/A

Market Cap/Employee

$842.22K

N/A

Employees

18

N/A

Net Income

-$962.91K

-165.3%

EBITDA

-$980.07K

+46.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$8.80M

+249.7%

Total Debt

$22.55K

-82.7%

Accounts Receivable

$140.84K

-81.5%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$22.55K

-80.6%

Return on Assets

-1.30%

N/A

Return on Invested Capital

-67.21%

N/A

Free Cash Flow

-$1.44M

+32.2%

Operating Cash Flow

-$1.44M

+32.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SGMOSangamo Therapeutics, Inc.
$0.05+0.00%
IMDXInsight Molecular Diagnostics Inc.
$5.42+0.37%
IPHAInnate Pharma S.A.
$1.80+0.56%
TNXPTonix Pharmaceuticals Holding Corp.
$12.75-3.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$24.22+0.05%
AALAmerican Airlines Group
$17.92+0.00%
SMCISuper Micro Computer
$28.15-0.08%
TAT&T
$21.82-0.04%

Questions About HIND

What is the current price of Vyome?

Vyome is trading at $2.19 per share.

What is the 52-week range for Vyome?

Over the past 52 weeks, Vyome has traded between $1.75 and $18.60.

How much debt does Vyome have?

As of the most recent reporting period, Vyome reported total debt of $22.55K.

How much cash does Vyome have on hand?

Vyome reported $8.80M in cash and cash equivalents in its most recent financial results.

What is Vyome’s dividend yield?

Vyome does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.